Biolase Technology, Inc.
412 articles with Biolase Technology, Inc.
BIOLASE and TeamSmile Expand Initiative of Oral Health Day to Students in Kansas City Public Schools
Players and mascot "Blue the Dog" from Sporting Kansas City will be in attendance to meet and greet the students and support the program
BIOLASE, TeamSmile and Los Angeles Chargers to Host Oral Health Fair for Students from Los Angeles Public Schools
Chargers wide receiver Geremy Davis, running back Justin Jackson and the Charger Girls to meet the students and support necessary cause
BIOLASE, Inc., the global leader in dental lasers, announced that it will be presenting at the second annual LD Micro Virtual Investor Conference on Wednesday, March 13th at 10:40 am PT.
BIOLASE, Inc., the global leader in dental lasers, reported net revenue of $13.0 million and $46.2 million for the fourth quarter and year ended December 31, 2018, respectively.
BIOLASE appoints Sinclair Dental, the fastest growing full-service dental supply company in Canada, as the exclusive distributor and representative for the sales, service and support of BIOLASE's products
BIOLASE, Inc. announced that it will release fourth quarter 2018 financial and operating results on Tuesday, March 5, 2019 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to present at the following two investor conferences in December.
BIOLASE, Inc. today announced that it will release third quarter 2018 financial and operating results on Monday, November 12, 2018.
BIOLASE and Los Angeles Chargers Host TeamSmile Event to Increase Access to Oral Health for Children in Underserved Communities
Players and cheerleaders from the LA Chargers will be at the event to greet the children as they're offered free dental care
Southern California Market Initiative Showing Early Signs of Success as Core Laser Revenue in the Region Increased Almost 200% from Prior-Year Quarter
John R. Beaver Promoted to Executive Vice President and Chief Financial Officer
BIOLASE, Inc. announced that the Company will host a conference call on Wednesday, August 8, 2018, at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter ended June 30, 2018, and to answer questions.
BIOLASE, Inc. that it has appointed veteran senior dental industry executive, Todd A. Norbe and veteran senior finance executive Jess Roper to its Board of Directors, effective immediately.
BIOLASE, Inc. announced that it has received a letter from Nasdaq Listing Qualifications confirming that the Company has regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market.
Biolase Announces 1-for-5 Reverse Stock Split Common Stock Will Begin Trading On Split-Adjusted Basis On May 11
BIOLASE, Inc. announced today that at its annual meeting of stockholders held on May 9, 2018, the Company's stockholders granted the Board of Directors the discretion to effect a reverse stock split of BIOLASE's common stock at a ratio of not less than 1-for-5 and not more than 1-for-15.
BIOLASE Board Of Directors Asks Chairman Jonathan T. Lord, M.D. To Take On Expanded Leadership Role And Explore Strategic Options
NAMES CURRENT CFO JOHN R. BEAVER AS INTERIM CHIEF EXECUTIVE OFFICER
Biolase, Inc. reported its financial results for its fourth quarter and year ended December 31, 2017.
Will Help Fund Future Growth as Company Moves Toward Achieving Positive Operating Cash Flow and Profitability Goals
As previously disclosed, BIOLASE received notice from Nasdaq on August 9, 2017, that it was not in compliance with the Bid Price Requirements for its common stock.
Biolase responded to the latest attempt by CAO Group to use patent litigation to try to improve its competitive position in the marketplace.